Read our current newsletter and check our calendar of events to find out what activities and opportunities are available this quarter.
News & Notes
The Food and Drug Administration has fast-tracked L1-79, a drug designed to treat the “core symptoms” of autism. This is the second drug for autism that has received an accelerated approval process from the FDA in 2018.
Autism Speaks is putting big money behind efforts to train people with autism to code, betting that the unique talents of those on the spectrum pair well with the high-demand field.
Mayra and Roberto Contreras never imagined that, after years of medical school, they would wind up in the toy business. But when the Seal Beach couple learned their first child, Olivia Rose, had Down syndrome, life suddenly took them on an unexpected journey.